Melatonin is not a reliable treatment for depression on its own. A systematic review and meta-analysis pooling data from multiple clinical trials found that melatonin did not produce a statistically significant reduction in depressive symptoms compared to placebo. That said, the picture is more nuanced than a flat “no.” Certain doses, durations, and contexts showed modest benefits, and melatonin’s role in resetting disrupted sleep and circadian rhythms may indirectly help some people with depression.
What the Clinical Evidence Shows
When researchers combined data across all available trials, melatonin’s overall effect on depression scores was small and not statistically significant. The pooled effect size was just -0.17, which in practical terms means the average person taking melatonin barely scored differently on depression questionnaires than the average person taking a sugar pill.
However, the results varied depending on how depression was measured. Studies that used the Beck Depression Inventory, a self-reported questionnaire where people rate their own mood and functioning, found a meaningful benefit. In those trials, melatonin produced a moderate effect size of -0.52, which is considered clinically meaningful. Other measurement tools, including clinician-rated scales, showed no significant improvement. One possible explanation: melatonin may improve how people feel day to day, particularly around sleep, energy, and motivation, in ways that show up more clearly on self-report measures than on clinical interviews.
The strongest signal came from a specific protocol: 10 mg of melatonin daily for 12 weeks. Three studies using that regimen found a larger effect size of -0.63, suggesting that both the dose and the duration matter. Short courses or low doses may simply not move the needle.
Why Melatonin and Depression Are Connected
Melatonin is best known as a sleep hormone, but its relationship to mood runs deeper than that. Your brain’s master clock, a tiny region in the hypothalamus, coordinates the timing of hormone release, body temperature, alertness, and dozens of other processes throughout the day. When this internal timing system falls out of sync with your actual schedule or with the light-dark cycle, the ripple effects touch mood, energy, appetite, and concentration: the very symptoms that define depression.
Depression, bipolar disorder, and seasonal affective disorder are all associated with major disruptions in these daily rhythms. People with depression often have delayed or flattened melatonin cycles, meaning their body’s internal clock is drifting. Melatonin supplements can help re-anchor that clock to an appropriate schedule, and properly aligning circadian rhythms appears to have antidepressant effects. Research on seasonal depression specifically suggests that correcting the phase shift in circadian rhythms, whether through morning bright light or timed melatonin, is what produces the therapeutic benefit.
So melatonin’s potential value in depression likely has less to do with mood chemistry directly and more to do with restoring the biological timing that healthy mood depends on.
Melatonin Alongside Antidepressants
One of the more interesting findings involves combining melatonin with standard antidepressants. In preclinical research, neither a common SSRI antidepressant nor melatonin alone reversed depression-like behavior at lower doses. But the combination of the two normalized behavior, suggesting a synergistic effect. The combination appeared to work by restoring a key growth-signaling pathway in the hippocampus, a brain region involved in mood regulation, that neither treatment could restore on its own.
This is still early-stage evidence from animal studies, not something that translates directly into a recommendation. But it aligns with a broader idea in psychiatry: that fixing circadian disruption alongside targeting brain chemistry may produce better outcomes than either approach alone. In fact, one prescription antidepressant already on the market was designed around this concept, combining action on serotonin receptors with action on melatonin receptors.
The Sleep Connection
Sleep problems and depression feed each other in a well-documented cycle. Poor sleep worsens mood, and depression makes it harder to fall asleep, stay asleep, or wake up feeling rested. Roughly 75% of people with depression report some form of sleep disturbance.
Melatonin reliably improves sleep onset, total sleep time, and sleep quality. If disrupted sleep is fueling or maintaining your depressive symptoms, getting that under control can create real improvement in how you feel during the day. This may partly explain why trials using self-reported depression measures showed benefits while clinician-rated scales did not: people sleeping better genuinely feel better, even if their clinical depression scores haven’t shifted dramatically.
Dosage and Timing
The trials showing the clearest benefit used 10 mg nightly for at least 12 weeks. This is notably higher than the 0.5 to 3 mg range typically recommended for sleep alone. Lower doses and shorter courses generally did not produce significant improvements in depression scores.
Timing also matters. For circadian rhythm correction, melatonin is typically taken in the evening, but the optimal window depends on whether your internal clock is running late or early relative to your schedule. Taking melatonin several hours before your desired bedtime can shift your clock earlier, which is the direction most people with depression need.
Safety With Long-Term Use
Melatonin is generally well tolerated even with extended use. Studies tracking chronic melatonin supplementation have not found evidence of significant side effects or the development of tolerance, meaning you don’t need increasing doses over time to get the same effect. The most commonly reported issues are mild: about 5% of users report daytime fatigue, and roughly 3% report mood swings. There is no evidence that taking melatonin long-term suppresses your body’s ability to produce it naturally.
That said, melatonin supplements are regulated as dietary supplements in the United States, not as medications. Independent testing has found that the actual melatonin content in over-the-counter products can vary widely from what the label states, sometimes by as much as 400%. Choosing a product with third-party testing (look for USP or NSF certification) reduces this risk.
The Bottom Line on Melatonin and Depression
Melatonin is not a standalone antidepressant. The overall clinical evidence does not support using it as a primary treatment for major depression. Where it may play a useful supporting role is in situations where disrupted sleep or misaligned circadian rhythms are a significant part of the picture, particularly seasonal depression or depression marked by insomnia. Higher doses (around 10 mg) taken consistently over several months showed the most promise in trials. For people already on antidepressants, melatonin may offer a complementary benefit, though that evidence is still preliminary. It’s best understood as a circadian rhythm tool that can create conditions more favorable for mood recovery, not as a direct mood treatment.